Are Primary Care Claim Denials Increasing Revenue Loss?

Image
Yes,  primary care claim denials are increasingly contributing to revenue loss for physician practices by delaying reimbursements, increasing administrative workload, and weakening overall revenue integrity. As payer scrutiny intensifies and documentation requirements expand, primary care practices across the country are seeing a measurable rise in denial rates that directly affect operational stability and financial outcomes. Primary care providers operate on high patient volumes and relatively thin margins. When denials increase—even slightly—the cumulative impact can significantly reduce collections and ultimately affect a practice’s ability to yield EBITDA . Understanding why these denials occur and how to prevent them is essential for maintaining a healthy revenue cycle. The Growing Impact of Primary Care Claim Denials In recent years, payers have strengthened claim review processes, automated adjudication systems, and documentation requirements. These changes have led to...

Price Transparency for Durable Medical Equipment


Price transparency refers to the extent to which information is obtainable. It is when all parties in trading are aware of the product pricing i.e. awareness and knowledge of the bid price and asks price at various price levels, along with the quantities of any good or service involved. This also results in discrepancies in the billing and coding, thus affecting
 revenue cycle management.

DME refers to equipment such as oxygen supplies, wheelchairs, knee braces, etc. It has to be prescribed by a medical practitioner and the person buys this equipment from a DME provider or sometimes, the doctor himself calls a DME company for delivering it straight to the patient's home. This is where the price transparency has a catch. A knee brace could cost anywhere from a range of $250 to $1500 from two different DME companies. DME billing then gets erroneous due to double bills and unsuitable expenses.

Effects of Price Transparency-
DME billing takes a course on patients also as sometimes insurances have a set limit on what they can pay for the DME equipment. If the cost goes beyond that limit, the patient ends up paying himself. Overpayments occurring in DME billing are mainly due to price transparency being available on the web and various catalog prices. Again, due to changes in methods of production, market variations, and product innovations, Medicare ends up paying much more overall for DMEPOS (paying the market price for dressings-surgical but overpaying for wheelchairs). Especially in expensive and specialized medical devices, there are very few competitors; devices such as implantable cardioverter defibrillators (ICDs), pacemakers, etc. fall under the label of "differentiated oligopoly" category. Manufacturers do not set a single price for such products and charge different prices from different buyers (sellers have control over the prices they sell at).

To get more information about Price Transparency for DME click here: https://bit.ly/3SQ7rYZ.

Comments

Popular posts from this blog

How to Reduce Days in A/R with Smart Denial Management Strategies

How Outsourced Medical Billing Can Improve Your Practice’s Profitability

Is Your Neurology Billing Outsourcing Helping or Hurting You at Year-End?